Weleda achieved record sales in the 2024 financial year
Weleda AG, the global market leader for certified natural cosmetics and anthroposophic medicines, can look back on a very successful financial year 2024: Turnover increased by 8.3% to EUR 456.2 million (previous year: EUR 421.2 million) - the highest turnover in the company's history.

Weleda can look back on a very successful financial year 2024: On the one hand, record sales were achieved and, on the other, profitability improved significantly. Both main business segments and all regions worldwide contributed to the dynamic growth: sales in the cosmetics business increased by 8.2 percent to EUR 367.9 million (previous year: EUR 340.1 million), while the pharmaceutical division increased its sales by 8.7 percent to EUR 88.3 million (previous year: EUR 81.2 million). "2024 was the year of renewal for Weleda, and it was also a very strong year for us economically. Our good performance shows that our strategy of growth with responsibility is successful," says Tina Müller, CEO of Weleda AG. "We have taken the appropriate measures to further strengthen our competitiveness and resilience. Our focus on the four growth levers of innovation, premiumization, digitalization and internationalization is exactly right."
Internationalization driven forward - core region D-A-CH recovers significantly
Weleda further expanded its international business last year and achieved double-digit sales growth in major markets such as Asia and the USA, as well as in Eastern Europe, Southern Europe and Benelux. Weleda is also clearly back on course for growth in its core region D-A-CH after some challenging years. In Germany, the largest single market, Weleda achieved a 6.2 percent increase in sales. In Switzerland, sales increased by 7.4 percent. This positive development in the D-A-CH region was also supported by the new web stores in Switzerland and Germany, which successfully went live in spring 2024.
Weleda was also very innovative in 2024. New products such as the rejuvenating facial care Blue Gentian & Edelweiss and the expansion of the rosemary hair care range were important sales drivers in the cosmetics business. In the pharmaceuticals sector, the concentration on a focus range for the application areas of eye, stress & sleep and digestion had a positive effect on business development. Eye preparations made a particular contribution to growth with a 32% increase in sales.
Reduced complexity - increased efficiency
As part of a new organizational structure, which came into force at the beginning of 2024, Weleda introduced the Cosmetics and Pharma business units and thus transferred more entrepreneurial responsibility to their operational areas. In addition, strong central functions have been established and competencies pooled across the company. "The new organizational structure has made us faster, more efficient and more powerful. This benefits our customers worldwide," explains Tina Müller.
Sustainable out of conviction
Despite all the renewal, Weleda remains true to itself, the company writes in its press release. Sustainability continues to form the foundation of the business model, it says. Weleda is committed to protecting biodiversity and preserving healthy soils and is strengthening the circular economy. Last year, Weleda further sharpened its sustainability strategy and defined ambitious goals. The company is aiming to achieve net zero for its Scope 1 and 2 emissions by 2040 and to reduce Scope 3 emissions by 80 percent by that date.
On course for stable growth with innovations
The success story is set to continue. Innovations should pave the way for this. The recently launched multi-generational minLen line is the first of a whole series of new product ranges in the cosmetics business that Weleda will introduce to the market in 2025. With this - as with the new Weleda Cell Longevity facial care - Weleda is moving more towards premium products and expanding its sales channels. Both product lines will be available in perfumeries, according to the announcement.
Weleda also wants to strengthen its innovative power in the pharmaceutical business. The company has put together an interdisciplinary team under the name "Futurum" with the aim of further developing its anthroposophic medicines and underpinning them more strongly with scientific studies or bringing new forms of application to the market for the benefit of patients.
A sustainably successful future with a new brand image
Weleda is also increasingly appealing to younger target groups. The company has modernized its brand image, making it younger and more valuable at the same time, including the logo. The logo is now supplemented by a word mark that clearly emphasizes the company's values and origins: "Natural Science" or "Swiss Natural Science". Weleda products are and remain certified natural products. At the same time, the company uses the findings of its research and development activities to optimize the natural power of medicinal plants in such a way that they achieve the best possible effectiveness when used and strengthen vitality. Weleda will be present everywhere on the market with its new image in the course of the year.
Source and further information